Published: May 11, 2020, 03:20 IST | Updated: May 11, 2020, 03:20 IST
The U.S. Department of Health and Human Services (HHS) said on Saturday it would allow state health departments to distribute Gilead Sciences Inc’s remdesivir drug to fight COVID-19